Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-19
1998-01-20
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544283, 544284, 544287, 544293, A61K 31505, C07D23988, C07D23993, C07D23994
Patent
active
057101582
ABSTRACT:
This invention relates to the modulation and/or inhibition of cell signaling, cell proliferation, cell inflammatory response, the control of abnormal cell growth and cell reproduction. More specifically, this invention relates to the use of mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in inhibiting cell proliferation, including compounds which are useful protein tyrosine kinase (PTK) inhibitors. The method of treating cell proliferation using said quinazoline compounds and their use in pharmaceutical compositions is described.
REFERENCES:
patent: 3715358 (1973-02-01), Witzel et al.
patent: 3718743 (1973-02-01), Shen et al.
patent: 3971783 (1976-07-01), Barnish et al.
patent: 3985749 (1976-10-01), Foster
patent: 4322420 (1982-03-01), Kobayashi et al.
patent: 4343940 (1982-08-01), Kreighbaum
patent: 4464375 (1984-08-01), Kobayashi et al.
patent: 4465686 (1984-08-01), Lesher et al.
patent: 4599423 (1986-07-01), Lesher et al.
patent: 4661499 (1987-04-01), Young et al.
patent: 5457105 (1995-10-01), Barker
patent: 5580870 (1996-12-01), Barker et al.
Tetahedron, vol. 38, No. 22, pp. 3347-3354 (1982), Tamano, Kodama, Nakajima, Kumada, Minato, Suzuki, Nickel-Phosphine Complex-Catalyzed Grignard Coupling--II Grignard Coupling of, English Original.
Synthesis, pp. 564-565 (Jul. 1986), Yamamoto, Azuma, Mitoh, General Method for Synthesis of Bipyridines: Palladium Catalyzed Cross-Coupling Reaction of, English Original.
Chem. Pharm. Bull., vol. 30, No. 6, pp. 2003-2010 (1982), Yamamoto, Yanagi, Studies on Organometallic Compounds. III. Reaction of Trimethylstannylazines with Acyl Chlorides. A Novel C--C, English Original.
Heterocycles, vol. 23, No. 9, pp. 2375-2386 (1985), Ishikura, Oda, Terashima, A Simple and Regioselective Preparation of 2-or 3-Substituted Quinoline Derivatives Via, English Original.
J. Am. Chem. Soc., vol. 111, No. 3, pp. 877-891 (1989), Stern, Laguren-Davidson, Frank, Gui, Lin, Lu et al., Potential-Dependent Surface Chemistry of 3-Pyridinecarboxylic Acid (Niacin) and Related, English Original.
Chemical Abstract, vol. 84:164632t, p. 453 (1976), Yoshina, Quinoline Derivatives, English Abstract.
Chemical Abstract, vol. 103:123292z, p. 709 (1985), Barker, Huddleston, Clephane, Wood, Holmes, Dehalogenation of 1-Halothienyldi-and 1-Tetrahydroisoquinolines by Sodium Methoxide in, English Abstract.
Chemical Abstract, vol. 108:55860j, p. 704 (1988), Epling, Lin, Sulfur-Containing 2-Arylquinolinemethanols as Potential Antimalarials, English Abstract.
J. Heterocyclic Chem., vol. 20, pp. 1739-1740 (1983), Saeed, Ebraheem, Preparation of Phenylquinoxaline from alpha,alpha-Diaminoketones and, English Original.
Takase et al., Preparation of N-containing heterocyclic compounds as phosphodiesterase inhibitors, Chemical Abstracts, vol. 119:203427t, p. 898 (1993).
Budesinsky et al., Alkoxyquinazolines, Chemical Abstracts, Vo. 86:140078g, p. 569 (1977).
Barnish et al., Quinazoline derivatives, Chemical Abstracts, vol. 82:31349t, p. 503 (1975).
Marquis et al., Antithrombogenic quinazolines, Chemical Abstracts, vol. 77:70423d, p. 59 (1972).
Cronin et al., Hypotensive and bronchodilatory quinolines, isoquinolines, and quinazolines, Chemical Abstracts, vol. 70:68419, p. 397 (1969).
Takase et al., Cyclic GMP Phosphodiesterase Inhibityors. 2. Requirement of 6-Substitution of Quinazoline Derivatives for Potent and Selective Inhibitory Activity, J. Med. Chem., vol. 37, pp. 2106-2111 (1994).
Byford et al., o-Aminophenyl alkyl/aralkyl ketones and their derivativbes, Chemical Abstracts, vol. 111:39292g, p. 594 (1989).
Gopinathan et al., Ruthenium(II) complexes containing nitrogen heterocyclics, Chemical Abstracts, vol. 106:206623w, p. 704 (1987).
Lin et al., Studies on antiarrhythmics, Chemical Abstracts, vol. 96:122728w, p. 695 (1982).
Lederer et al., New synthesis of quazodine-type 7-methoxy-and 6,7-dimethoxyquinazolines, Chemical Abstracts, vol. 84:105533p, p. 575 (1976).
Maguire Martin P.
Myers Michael R.
Persons Paul E.
Spada Alfred P.
Cebulak Mary C.
Dees Jos,e G.
Nicholson James A.
Parker III Raymond S.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
LandOfFree
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl and heteroaryl quinazoline compounds which inhibit EGF and/, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl and heteroaryl quinazoline compounds which inhibit EGF and/ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-725607